Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians:: Identification of a Pro12Ala PPARγ2 missense mutation

被引:439
作者
Yen, CJ
Beamer, BA
Negri, C
Silver, K
Brown, KA
Yarnall, DP
Burns, DK
Roth, J
Shuldiner, AR
机构
[1] Univ Maryland, Sch Med, Div Diabet Obes & Nutr, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD USA
[3] Glaxo Wellcome, Res Triangle Pk, NC USA
关键词
D O I
10.1006/bbrc.1997.7798
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator activated receptor-gamma (PPAR gamma) is a nuclear receptor that regulates adipocyte differentiation, and possibly lipid metabolism and insulin sensitivity. As such, PPAR gamma is a promising candidate gene for several human disorders including obesity and type 2 diabetes mellitus. Screening for mutations in the entire coding region of the PPAR gamma gene (both gamma 1 and gamma 2 isoforms) was performed with DNA of 26 diabetic Caucasians with or without obesity. Two base substitutions were identified: a silent mutation at nucleotide 1431 (CAC(His) --> CAT(His)) and a missense mutation (CCG(Pro) --> GCG(Ala)) at codon 12 of PPAR gamma 2. The allele frequency of the Pro12Ala PPAR gamma 2 variant was 0.12 in Caucasian Americans, 0.10 in Mexican Americans, 0.08 in Samoans, 0.03 in African Americans, 0.02 in Nauruans, and 0.01 in Chinese. We conclude that the Pro12Ala PPAR gamma 2 gene variant is present in diverse populations. Further studies of the Pro12Ala variant will determine its relevance to obesity, insulin resistance, and type 2 diabetes. (C) 1997 Academic Press.
引用
收藏
页码:270 / 274
页数:5
相关论文
共 24 条
  • [1] Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone
    Antonucci, T
    Whitcomb, R
    McLain, R
    Lockwood, D
    [J]. DIABETES CARE, 1997, 20 (02) : 188 - 193
  • [2] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
    Auboeuf, D
    Rieusset, J
    Fajas, L
    Vallier, P
    Frering, V
    Riou, JP
    Staels, P
    Auwerx, J
    Laville, M
    Vidal, H
    [J]. DIABETES, 1997, 46 (08) : 1319 - 1327
  • [3] Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene
    Beamer, BA
    Negri, C
    Yen, CJ
    Gavrilova, O
    Rumberger, JM
    Durcan, MJ
    Yarnall, DP
    Hawkins, AL
    Griffin, CA
    Burns, DK
    Roth, J
    Reitman, M
    Shuldiner, AR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) : 756 - 759
  • [4] Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice
    Berger, J
    Bailey, P
    Biswas, C
    Cullinan, CA
    Doebber, TW
    Hayes, NS
    Saperstein, R
    Smith, RG
    Leibowitz, MD
    [J]. ENDOCRINOLOGY, 1996, 137 (10) : 4189 - 4195
  • [5] An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissue
    Berger, J
    Biswas, C
    Hayes, N
    Ventre, J
    Wu, M
    Doebber, TW
    [J]. ENDOCRINOLOGY, 1996, 137 (05) : 1984 - 1990
  • [6] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-GAMMA - ADIPOSE-PREDOMINANT EXPRESSION AND INDUCTION EARLY IN ADIPOCYTE DIFFERENTIATION
    CHAWLA, A
    SCHWARZ, EJ
    DIMACULANGAN, DD
    LAZAR, MA
    [J]. ENDOCRINOLOGY, 1994, 135 (02) : 798 - 800
  • [7] Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2
    Elbrecht, A
    Chen, YL
    Cullinan, CA
    Hayes, N
    Leibowitz, MD
    Moller, DE
    Berger, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) : 431 - 437
  • [8] The organization, promoter analysis, and expression of the human PPAR gamma gene
    Fajas, L
    Auboeuf, D
    Raspe, E
    Schoonjans, K
    Lefebvre, AM
    Saladin, R
    Najib, J
    Laville, M
    Fruchart, JC
    Deeb, S
    VidalPuig, A
    Flier, J
    Briggs, MR
    Staels, B
    Vidal, H
    Auwerx, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18779 - 18789
  • [9] 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA
    FORMAN, BM
    TONTONOZ, P
    CHEN, J
    BRUN, RP
    SPIEGELMAN, BM
    EVANS, RM
    [J]. CELL, 1995, 83 (05) : 803 - 812
  • [10] NEW ORAL THIAZOLIDINEDIONE ANTIDIABETIC AGENTS ACT AS INSULIN SENSITIZERS
    HOFMANN, CA
    COLCA, JR
    [J]. DIABETES CARE, 1992, 15 (08) : 1075 - 1078